Post-IPO Debt - Sunesis Pharmaceuticals
Investment Firm
Overview
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Announced Date
Apr 01, 2016
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Sunesis Pharmaceuticals raised $15000000 on 2016-04-01 in Post-IPO Debt
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 01, 2015 |  Post-IPO Equity - Sunesis Pharmaceuticals | - | 25.0M | |
| Oct 19, 2016 | Post-IPO Equity - Sunesis Pharmaceuticals | - | 25.0M | |
| Apr 01, 2016 | Post-IPO Debt - Sunesis Pharmaceuticals | 1 | - | 15.0M |
| Apr 07, 2009 | Post-IPO Equity - Sunesis Pharmaceuticals | 9 | - | 43.5M |
Recent Activity
There is no recent news or activity for this profile.